Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · IEX Real-Time Price · USD
3.480
+0.240 (7.41%)
At close: Jul 19, 2024, 4:00 PM
3.420
-0.060 (-1.72%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $204.93 million as of July 22, 2024. Its market cap has increased by 121.31% in one year.
Market Cap
204.93M
Enterprise Value
67.21M
1-Year Change
121.31%
Ranking
Category
Stock Price
$3.48
Market Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $204.93M, a decrease of -60.87%. That is a compound annual growth rate of -28.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 204.90M | 156.77% |
| Dec 29, 2023 | 79.80M | 69.79% |
| Dec 30, 2022 | 47.00M | -86.92% |
| Dec 31, 2021 | 359.40M | -31.38% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| The Joint | 209.63M |
| Abeona Therapeutics | 209.32M |
| Shattuck Labs | 209.22M |
| Caribou Biosciences | 207.28M |
| Genfit | 207.00M |
| Biodesix | 202.99M |
| bluebird bio | 202.38M |
| CVRx, Inc. | 202.13M |